Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / Fund iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer Blackrock
Entity holding fund iShares Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF Ticker IDUS(USD) LSE
ETF Ticker IDUS.LS(USD) CXE
ETF Ticker IUSA.AS(EUR) CXE
ETF Ticker IUSA.DE(EUR) CXE
ETF Ticker IUSA.LS(GBX) CXE
ETF Ticker IUSA.MI(EUR) CXE
ETF Ticker IUSAz(USD) CXE
ETF Ticker IUSA(EUR) ETF Plus
ETF Ticker IDUS.L(GBP) LSE

Holdings detail for VRTX

Stock Name	Vertex Pharmaceuticals Inc
Ticker	VRTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92532F1003
LEI	54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY: (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse: Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul: Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now: Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now: Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now: Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August: Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR: The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News: The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares Core S&P 500 UCITS ETF USD (Dist) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-10-01 (Wednesday)	90,865	USD 36,728,542	USD 36,728,542
2025-09-29 (Monday)	90,865	USD 35,919,843	USD 35,919,843	0	USD 870,032	USD 395.31	USD 385.735
2025-09-26 (Friday)	90,865	USD 35,049,811	USD 35,049,811	0	USD 351,193	USD 385.735	USD 381.87
2025-09-25 (Thursday)	90,865	USD 34,698,618	USD 34,698,618	34	USD 489,847	USD 381.87	USD 376.62
2025-09-24 (Wednesday)	90,831	USD 34,208,771	USD 34,208,771	-674	USD -1,213,730	USD 376.62	USD 387.11
2025-09-18 (Thursday)	91,505	USD 35,422,501	USD 35,422,501	35	USD 9,890	USD 387.11	USD 387.15
2025-09-17 (Wednesday)	91,470	USD 35,412,611	USD 35,412,611	35	USD -371,391	USD 387.15	USD 391.36
2025-09-16 (Tuesday)	91,435	USD 35,784,002	USD 35,784,002	0	USD -169,154	USD 391.36	USD 393.21
2025-09-15 (Monday)	91,435	USD 35,953,156	USD 35,953,156

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE0031442068

Show aggregate share trades of VRTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 34 381.870* 457.94
2025-09-24 SELL -674 376.620* 458.34 Profit of 308,921 on sale
2025-09-18 BUY 35 387.110* 458.69
2025-09-17 BUY 35 387.150* 459.05
2025-08-19 SELL -70 390.760* 460.38 Profit of 32,227 on sale
2025-08-15 SELL -35 392.790* 461.09 Profit of 16,138 on sale
2025-08-13 SELL -175 395.920* 461.42 Profit of 80,749 on sale
2025-08-12 SELL -455 387.770* 461.81 Profit of 210,121 on sale
2025-08-07 SELL -525 375.630* 462.25 Profit of 242,683 on sale
2025-08-06 BUY 35 385.650* 462.66
2025-07-31 BUY 105 456.870* 463.15
2025-07-28 BUY 35 460.830* 463.10
2025-07-25 SELL -70 469.650* 463.07 Profit of 32,415 on sale
2025-07-24 BUY 35 472.270* 463.02
2025-07-18 BUY 35 459.810* 462.94
2025-07-14 SELL -35 472.350* 462.84 Profit of 16,199 on sale
2025-07-08 SELL -70 466.360* 462.63 Profit of 32,384 on sale
2025-07-02 BUY 210 457.030* 462.72
2025-06-24 SELL -70 450.270* 463.25 Profit of 32,428 on sale
2025-06-23 SELL -35 443.540* 463.38 Profit of 16,218 on sale
2025-06-20 BUY 51 440.870* 463.51
2025-06-12 SELL -105 460.060* 463.86 Profit of 48,706 on sale
2025-06-06 BUY 35 450.500* 464.22
2025-06-02 SELL -105 445.430* 464.72 Profit of 48,796 on sale
2025-05-29 SELL -35 447.090* 464.99 Profit of 16,275 on sale
2025-05-27 BUY 35 446.000* 465.26
2025-05-23 BUY 35 436.000* 465.67
2025-05-21 SELL -105 435.320* 466.10 Profit of 48,941 on sale
2025-05-16 SELL -419 438.650* 466.62 Profit of 195,514 on sale
2025-05-15 BUY 140 434.380* 466.85
2025-05-14 SELL -210 421.160* 467.19 Profit of 98,109 on sale
2025-05-13 SELL -420 432.000* 467.45 Profit of 196,327 on sale
2025-05-07 SELL -105 434.820* 468.51 Profit of 49,194 on sale
2025-05-02 SELL -35 501.150* 468.16 Profit of 16,386 on sale
2025-04-29 SELL -105 503.500* 467.31 Profit of 49,067 on sale
2025-04-24 BUY 35 492.470* 466.65
2025-04-22 BUY 140 490.470* 466.24
2025-04-16 BUY 35 485.890* 465.58
2025-04-15 BUY 35 500.490* 465.28
2025-04-11 BUY 70 484.220* 464.85
2025-04-09 BUY 175 482.300* 464.60
2025-04-08 BUY 525 472.370* 464.53
2025-04-07 SELL -245 474.560* 464.44 Profit of 113,787 on sale
2025-04-04 SELL -525 474.620* 464.34 Profit of 243,780 on sale
2025-04-02 SELL -105 483.490* 464.17 Profit of 48,737 on sale
2025-04-01 SELL -35 484.740* 463.97 Profit of 16,239 on sale
2025-03-31 SELL -70 484.820* 463.78 Profit of 32,464 on sale
2025-03-28 BUY 70 492.690* 463.50
2025-03-25 BUY 105 509.040* 462.31
2025-03-24 BUY 140 511.740* 461.82
2025-03-21 SELL -70 503.200* 461.41 Profit of 32,299 on sale
2025-03-20 BUY 70 510.180* 460.92
2025-03-19 BUY 140 512.520* 460.39
2025-03-17 SELL -105 513.760* 459.29 Profit of 48,226 on sale
2025-03-14 SELL -70 504.770* 458.81 Profit of 32,117 on sale
2025-03-13 SELL -210 502.920* 458.35 Profit of 96,253 on sale
2025-03-11 SELL -245 488.340* 457.62 Profit of 112,116 on sale
2025-03-10 SELL -140 500.010* 457.15 Profit of 64,001 on sale
2025-03-06 SELL -140 485.720* 456.48 Profit of 63,907 on sale
2025-03-05 SELL -210 491.640* 456.08 Profit of 95,777 on sale
2025-03-04 SELL -280 486.220* 455.73 Profit of 127,606 on sale
2025-02-28 SELL -175 479.790* 455.13 Profit of 79,647 on sale
2025-02-26 BUY 70 479.100* 454.60
2025-02-24 BUY 70 481.650* 453.95
2025-02-21 BUY 35 484.240* 453.57
2025-02-20 SELL -105 480.330* 453.24 Profit of 47,590 on sale
2025-02-14 SELL -35 459.000* 452.72 Profit of 15,845 on sale
2025-02-13 SELL -455 462.580* 452.58 Profit of 205,925 on sale
2025-02-12 SELL -35 453.200* 452.57 Profit of 15,840 on sale
2025-02-06 SELL -140 481.160* 451.63 Profit of 63,228 on sale
2025-02-05 BUY 35 488.440* 451.09
2025-02-04 SELL -1 482.280* 450.62 Profit of 451 on sale
2025-01-29 SELL -245 441.520* 450.47 Profit of 110,365 on sale
2025-01-28 BUY 70 440.680* 450.63
2025-01-24 BUY 35 439.620* 450.92
2025-01-22 BUY 70 428.000* 451.51
2025-01-16 BUY 70 416.960* 453.68
2025-01-15 BUY 35 424.260* 454.24
2025-01-10 BUY 70 409.560* 456.80
2025-01-02 BUY 105 405.760* 459.79
2024-12-31 BUY 70 402.700* 461.03
2024-12-27 BUY 35 408.760* 463.62
2024-12-20 BUY 105 397.270* 469.45
2024-12-19 BUY 35 396.640* 471.31
2024-12-18 SELL -35 447.500* 471.94 Profit of 16,518 on sale
2024-12-17 BUY 70 469.240* 472.01
2024-12-13 BUY 35 463.730* 472.36
2024-12-11 SELL -204 468.290* 472.48 Profit of 96,386 on sale
2024-12-10 BUY 35 469.220* 472.58
2024-12-06 SELL -70 462.100* 472.87 Profit of 33,101 on sale
2024-12-05 BUY 35 459.920* 473.30
2024-12-04 SELL -280 463.980* 473.62 Profit of 132,615 on sale
2024-12-03 BUY 105 456.970* 474.22
2024-12-02 BUY 175 465.730* 474.53
2024-11-27 BUY 35 464.560* 475.63
2024-11-26 BUY 245 467.070* 476.00
2024-11-21 BUY 105 450.370* 479.25
2024-11-20 BUY 70 451.230* 480.73
2024-11-19 BUY 35 448.010* 482.54
2024-11-18 BUY 70 467.010* 483.46
2024-11-12 BUY 140 490.000* 483.05
2024-11-11 BUY 70 501.720* 481.81
2024-11-08 BUY 280 516.740* 479.31
2024-11-07 BUY 245 502.450* 477.53
2024-11-06 BUY 280 493.640* 476.19
2024-11-05 SELL -70 499.880* 474.03 Profit of 33,182 on sale
2024-11-04 BUY 70 472.800* 474.16
2024-11-01 BUY 245 471.120* 474.49
2024-10-28 BUY 175 476.370* 474.53
2024-10-25 BUY 385 477.700* 473.74
2024-10-23 SELL -35 470.050* 476.50 Profit of 16,678 on sale
2024-10-21 BUY 35 478.090* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	34	381.870*	457.94
2025-09-24	SELL	-674	376.620*	458.34 Profit of 308,921 on sale
2025-09-18	BUY	35	387.110*	458.69
2025-09-17	BUY	35	387.150*	459.05
2025-08-19	SELL	-70	390.760*	460.38 Profit of 32,227 on sale
2025-08-15	SELL	-35	392.790*	461.09 Profit of 16,138 on sale
2025-08-13	SELL	-175	395.920*	461.42 Profit of 80,749 on sale
2025-08-12	SELL	-455	387.770*	461.81 Profit of 210,121 on sale
2025-08-07	SELL	-525	375.630*	462.25 Profit of 242,683 on sale
2025-08-06	BUY	35	385.650*	462.66
2025-07-31	BUY	105	456.870*	463.15
2025-07-28	BUY	35	460.830*	463.10
2025-07-25	SELL	-70	469.650*	463.07 Profit of 32,415 on sale
2025-07-24	BUY	35	472.270*	463.02
2025-07-18	BUY	35	459.810*	462.94
2025-07-14	SELL	-35	472.350*	462.84 Profit of 16,199 on sale
2025-07-08	SELL	-70	466.360*	462.63 Profit of 32,384 on sale
2025-07-02	BUY	210	457.030*	462.72
2025-06-24	SELL	-70	450.270*	463.25 Profit of 32,428 on sale
2025-06-23	SELL	-35	443.540*	463.38 Profit of 16,218 on sale
2025-06-20	BUY	51	440.870*	463.51
2025-06-12	SELL	-105	460.060*	463.86 Profit of 48,706 on sale
2025-06-06	BUY	35	450.500*	464.22
2025-06-02	SELL	-105	445.430*	464.72 Profit of 48,796 on sale
2025-05-29	SELL	-35	447.090*	464.99 Profit of 16,275 on sale
2025-05-27	BUY	35	446.000*	465.26
2025-05-23	BUY	35	436.000*	465.67
2025-05-21	SELL	-105	435.320*	466.10 Profit of 48,941 on sale
2025-05-16	SELL	-419	438.650*	466.62 Profit of 195,514 on sale
2025-05-15	BUY	140	434.380*	466.85
2025-05-14	SELL	-210	421.160*	467.19 Profit of 98,109 on sale
2025-05-13	SELL	-420	432.000*	467.45 Profit of 196,327 on sale
2025-05-07	SELL	-105	434.820*	468.51 Profit of 49,194 on sale
2025-05-02	SELL	-35	501.150*	468.16 Profit of 16,386 on sale
2025-04-29	SELL	-105	503.500*	467.31 Profit of 49,067 on sale
2025-04-24	BUY	35	492.470*	466.65
2025-04-22	BUY	140	490.470*	466.24
2025-04-16	BUY	35	485.890*	465.58
2025-04-15	BUY	35	500.490*	465.28
2025-04-11	BUY	70	484.220*	464.85
2025-04-09	BUY	175	482.300*	464.60
2025-04-08	BUY	525	472.370*	464.53
2025-04-07	SELL	-245	474.560*	464.44 Profit of 113,787 on sale
2025-04-04	SELL	-525	474.620*	464.34 Profit of 243,780 on sale
2025-04-02	SELL	-105	483.490*	464.17 Profit of 48,737 on sale
2025-04-01	SELL	-35	484.740*	463.97 Profit of 16,239 on sale
2025-03-31	SELL	-70	484.820*	463.78 Profit of 32,464 on sale
2025-03-28	BUY	70	492.690*	463.50
2025-03-25	BUY	105	509.040*	462.31
2025-03-24	BUY	140	511.740*	461.82
2025-03-21	SELL	-70	503.200*	461.41 Profit of 32,299 on sale
2025-03-20	BUY	70	510.180*	460.92
2025-03-19	BUY	140	512.520*	460.39
2025-03-17	SELL	-105	513.760*	459.29 Profit of 48,226 on sale
2025-03-14	SELL	-70	504.770*	458.81 Profit of 32,117 on sale
2025-03-13	SELL	-210	502.920*	458.35 Profit of 96,253 on sale
2025-03-11	SELL	-245	488.340*	457.62 Profit of 112,116 on sale
2025-03-10	SELL	-140	500.010*	457.15 Profit of 64,001 on sale
2025-03-06	SELL	-140	485.720*	456.48 Profit of 63,907 on sale
2025-03-05	SELL	-210	491.640*	456.08 Profit of 95,777 on sale
2025-03-04	SELL	-280	486.220*	455.73 Profit of 127,606 on sale
2025-02-28	SELL	-175	479.790*	455.13 Profit of 79,647 on sale
2025-02-26	BUY	70	479.100*	454.60
2025-02-24	BUY	70	481.650*	453.95
2025-02-21	BUY	35	484.240*	453.57
2025-02-20	SELL	-105	480.330*	453.24 Profit of 47,590 on sale
2025-02-14	SELL	-35	459.000*	452.72 Profit of 15,845 on sale
2025-02-13	SELL	-455	462.580*	452.58 Profit of 205,925 on sale
2025-02-12	SELL	-35	453.200*	452.57 Profit of 15,840 on sale
2025-02-06	SELL	-140	481.160*	451.63 Profit of 63,228 on sale
2025-02-05	BUY	35	488.440*	451.09
2025-02-04	SELL	-1	482.280*	450.62 Profit of 451 on sale
2025-01-29	SELL	-245	441.520*	450.47 Profit of 110,365 on sale
2025-01-28	BUY	70	440.680*	450.63
2025-01-24	BUY	35	439.620*	450.92
2025-01-22	BUY	70	428.000*	451.51
2025-01-16	BUY	70	416.960*	453.68
2025-01-15	BUY	35	424.260*	454.24
2025-01-10	BUY	70	409.560*	456.80
2025-01-02	BUY	105	405.760*	459.79
2024-12-31	BUY	70	402.700*	461.03
2024-12-27	BUY	35	408.760*	463.62
2024-12-20	BUY	105	397.270*	469.45
2024-12-19	BUY	35	396.640*	471.31
2024-12-18	SELL	-35	447.500*	471.94 Profit of 16,518 on sale
2024-12-17	BUY	70	469.240*	472.01
2024-12-13	BUY	35	463.730*	472.36
2024-12-11	SELL	-204	468.290*	472.48 Profit of 96,386 on sale
2024-12-10	BUY	35	469.220*	472.58
2024-12-06	SELL	-70	462.100*	472.87 Profit of 33,101 on sale
2024-12-05	BUY	35	459.920*	473.30
2024-12-04	SELL	-280	463.980*	473.62 Profit of 132,615 on sale
2024-12-03	BUY	105	456.970*	474.22
2024-12-02	BUY	175	465.730*	474.53
2024-11-27	BUY	35	464.560*	475.63
2024-11-26	BUY	245	467.070*	476.00
2024-11-21	BUY	105	450.370*	479.25
2024-11-20	BUY	70	451.230*	480.73
2024-11-19	BUY	35	448.010*	482.54
2024-11-18	BUY	70	467.010*	483.46
2024-11-12	BUY	140	490.000*	483.05
2024-11-11	BUY	70	501.720*	481.81
2024-11-08	BUY	280	516.740*	479.31
2024-11-07	BUY	245	502.450*	477.53
2024-11-06	BUY	280	493.640*	476.19
2024-11-05	SELL	-70	499.880*	474.03 Profit of 33,182 on sale
2024-11-04	BUY	70	472.800*	474.16
2024-11-01	BUY	245	471.120*	474.49
2024-10-28	BUY	175	476.370*	474.53
2024-10-25	BUY	385	477.700*	473.74
2024-10-23	SELL	-35	470.050*	476.50 Profit of 16,678 on sale
2024-10-21	BUY	35	478.090*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	253,408	88	822,586	30.8%
2025-09-18	262,277	45	831,580	31.5%
2025-09-17	158,866	890	1,012,591	15.7%
2025-09-16	233,484	702	769,823	30.3%
2025-09-15	385,606	97	605,410	63.7%
2025-09-12	198,306	54	325,925	60.8%
2025-09-11	217,651	160	455,823	47.7%
2025-09-10	441,550	65	640,409	68.9%
2025-09-09	216,563	711	395,377	54.8%
2025-09-08	285,371	226	594,102	48.0%
2025-09-05	209,916	9	413,663	50.7%
2025-09-04	236,777	2,164	365,713	64.7%
2025-09-03	212,085	7	457,751	46.3%
2025-09-02	318,587	425	689,371	46.2%
2025-08-29	136,055	7	344,317	39.5%
2025-08-28	189,040	229	437,536	43.2%
2025-08-27	204,685	373	919,772	22.3%
2025-08-26	195,209	380	616,641	31.7%
2025-08-25	205,216	929	405,536	50.6%
2025-08-22	187,538	366	477,729	39.3%
2025-08-21	357,256	454	694,264	51.5%
2025-08-20	304,195	196	620,591	49.0%
2025-08-19	193,253	370	598,168	32.3%
2025-08-18	197,043	357	581,908	33.9%
2025-08-15	213,454	413	509,240	41.9%
2025-08-14	299,335	536	798,768	37.5%
2025-08-13	342,897	6,746	694,047	49.4%
2025-08-12	361,071	536	689,425	52.4%
2025-08-11	478,787	177	1,141,772	41.9%
2025-08-08	382,688	480	1,467,480	26.1%
2025-08-07	802,775	500	1,747,924	45.9%
2025-08-06	1,070,384	29,978	2,256,489	47.4%
2025-08-05	2,087,742	66,027	4,981,303	41.9%
2025-08-04	329,631	253	766,131	43.0%
2025-08-01	290,545	239	729,079	39.9%
2025-07-31	227,826	151	513,336	44.4%
2025-07-30	134,793	234	361,144	37.3%
2025-07-29	124,474	331	372,446	33.4%
2025-07-28	125,989	264	519,868	24.2%
2025-07-25	136,582	104	432,897	31.6%
2025-07-24	144,869	169	321,736	45.0%
2025-07-23	182,307	1,460	370,788	49.2%
2025-07-22	193,759	402	450,155	43.0%
2025-07-21	174,382	14,621	318,671	54.7%
2025-07-18	203,357	10,091	296,802	68.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDUS(USD) LSE
ETF Ticker	IDUS.LS(USD) CXE
ETF Ticker	IUSA.AS(EUR) CXE
ETF Ticker	IUSA.DE(EUR) CXE
ETF Ticker	IUSA.LS(GBX) CXE
ETF Ticker	IUSA.MI(EUR) CXE
ETF Ticker	IUSAz(USD) CXE
ETF Ticker	IUSA(EUR) ETF Plus
ETF Ticker	IDUS.L(GBP) LSE